Nadia Hameed, MD

Physician, GYN Pathologist, Assistant Professor, UT-MD Anderson Cancer Center

[Nadia Hameed, MD @NadiaUSAMC]

@Sinchita_Roy @cytopathology Congratulations 🎉🎊

[Kee-Taek Jang @ktjang12]

Group photos of the gala dinner in KSP 2025.

[Nadia Hameed, MD @NadiaUSAMC]

Seoul-A paradise of food lovers😋😋

[Woo Cheal Cho, MD @DrAldehyde]

The #MDACCPath William Russell Annual Conference is just a month away! This year, join us for a two-day course at the Health Museum with an amazing lineup of expert faculty.

Don’t miss out—register now and be part of the #pathology excitement! 😆🔬

[Nadia Hameed, MD @NadiaUSAMC]

A great talk on Next-generation immunohistochemistry for the diagnosis of soft tissue tumors by @JLHornick at #KSP2025 @DrAldehyde

[Nadia Hameed, MD @NadiaUSAMC]

So great to be part of #KSP25 @KSPathology this year! learning from inspiring colleagues, and catching up with friends in pathology. ❤️🔬 #KSP2025

[Nadia Hameed, MD @NadiaUSAMC]

10th Anniversary of MD Anderson’s Boot Walk to End Cancer on Sunday, Nov 15
Register to walk the 1.2 mikes in person at Texas Medical Center’s Helix Park or sign up to walk in your own neighborhood
[email protected]

[Nadia Hameed, MD @NadiaUSAMC]

Micropapillary and cribriform patterns in Serous Borderline Tumor

[Nadia Hameed, MD @NadiaUSAMC]

@sciqst It is associated with a very aggressive clinical course.

[Nadia Hameed, MD @NadiaUSAMC]

Pilomatrix-like High Grade endometrioid Adenocarcinoma of the ovary
1. Basaloid nests
2. Necrosis
3. Abrupt keratinization
4. Ghost “ shadow” cells

[Diagnexia @diagnexia]

Upcoming LATAM Webinar – 9/18 at 4:00 PM GMT
🎙️ Dr. Victor Prieto:
"Uso de inmunoterapia en pacientes con neoplasias cutáneas: indicaciones y evaluación"
📌 ¡Webinar en español!
🔗 Regístrate: https://t.co/2R1vC3buWv
#Diagnexia #LatamWebinar #Dermatopatología #Inmunoterapia

[Elvio Silva, MD @ElvioSilvaMD]

Ovarian cancer. Questions re the theory included in the book Fere Ex Nihilo. Q-How is it possible that pathologists have not reported abnormalities in the residual ovarian tissue?A-Pathologists diagnose and classify lesions. We are not trained, and we do not have the time needed to look at the residual organ. In addition, to see subtle cases, you need to see numerous cases. I became interested in this issue, and I have the time and the possibility to see many cases.

[Nadia Hameed, MD @NadiaUSAMC]

#KSP2024

[Nadia Hameed, MD @NadiaUSAMC]

@LotteHotelSeoul
KSP annual meeting
Thank you for the wonderful hospitality and experience!
@DrAldehyde

[Nadia Hameed, MD @NadiaUSAMC]

@Drsurgicalpath [email protected]

[Nadia Hameed, MD @NadiaUSAMC]

I am happy to announce that our GME office has approved a 2nd position for a GYN Pathology Fellowship at MDACC. If you are interested pls contact me. Start date is July 2024. I’m aware this is on short notice but it is a great opportunity to work with expert GYN Pathologists.

[محمد المعتاز @AlmoatazMHD]

@Byoussef كفيت ووفيت.

[Bassem Youssef @Byoussef]

Full interview :

https://t.co/KOQZFAYsrF

[Elvio Silva, MD @ElvioSilvaMD]

Unusual case. History: Endocx adenoCa in-situ. Developed an ovarian mass simulating an adenofibroma with very few glands in a fibromatous stroma, some without epithelial stratification. Fortunately we did HR HPV. Diag: Mets endocervical adenoCa.

[Elvio Silva, MD @ElvioSilvaMD]

Multicentricity in ovarian serous Ca. If we find this over and over, it must b true. LGSCa near Endosalpingiosis in peritoneum. Hum Path 10.1016, 2022. Two cases in one day.⁦@IJGConline⁩